Issue 18, 2020

Anticancer potency of novel organometallic Ir(iii) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles

Abstract

Novel half-sandwich iridium(III) complexes with aminomethyl(diphenyl)phosphine derived from fluoroloquinolones (IrPCp, IrPSf, IrPLm, IrPNr) were studied as possible anticancer chemotherapeutics and showed higher potency than other well-known metal-based agents i.e., Pt(II) drugs. All compounds were characterized by elemental analysis, selected spectroscopic methods (i.e., absorption and fluorescence spectroscopy, NMR), ESI-MS spectrometry, X-ray diffraction, and electrochemical techniques. The studied complexes exhibited promising cytotoxicity in vitro with IC50 values significantly lower than that of the reference drug – cisplatin. The insight into the mode of action revealed the uniform distribution of the Ir(III) complexes in both the nucleus and cytoplasm (Pearson's co-localization coefficient of 0.63). Precise cytometric analysis provided clear evidence for the predominance of apoptosis in the induced cell death. The activation of caspase-3/7 along with the decrease of mitochondrial membrane potential also confirmed the apoptotic cell death. The investigated Ir(III) complexes may induce changes in the cell cycle leading to G2/M phase arrest. ROS generation as a plausible pathway responsible for the cytotoxicity was confirmed by determination of redox potentials enabling efficient ROS production. Furthermore, Pluronic P-123 micelles loaded with selected Ir(III) complexes were proposed to overcome low solubility and to minimize serious systemic side effects by administering the complex in a controlled manner. The resulting nanoformulations (IrPCp_M, IrPNr_M) facilitated efficient drug accumulation for human lung adenocarcinoma and human prostate carcinoma (A549 and DU-145 cell lines), as demonstrated by confocal microscopy and ICP-MS analysis. In vitro cytotoxicity assays were also carried out within multicellular tumor spheroids and efficient anticancer action on these 3D assemblies was demonstrated.

Graphical abstract: Anticancer potency of novel organometallic Ir(iii) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles

Supplementary files

Article information

Article type
Research Article
Submitted
07 May 2020
Accepted
20 Jul 2020
First published
23 Jul 2020

Inorg. Chem. Front., 2020,7, 3386-3401

Anticancer potency of novel organometallic Ir(III) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles

S. Kozieł, U. K. Komarnicka, A. Ziółkowska, A. Skórska-Stania, B. Pucelik, M. Płotek, V. Sebastian, A. Bieńko, G. Stochel and A. Kyzioł, Inorg. Chem. Front., 2020, 7, 3386 DOI: 10.1039/D0QI00538J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements